HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
about
The Impact of Sparse Follow-up on Marginal Structural Models for Time-to-Event Data.Gender influences on hepatitis C incidence among street youth in a Canadian setting.HIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infectionsAscertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designTwin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian AboriginalCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbiditiesTreatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Knowledge, attitude and behaviour regarding hepatitis C virus infection amongst Brazilian dental students.Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.Declining mortality among HIV-positive indigenous people at a Vancouver indigenous-focused urban-core health care centre.Advances in the treatment of HIV/HCV coinfection in adults.Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients
P2860
Q31026915-0ADE1CC4-98C1-483D-839D-B09722FDB6BDQ34622596-C1AA368C-03AD-4DF7-A49B-E741C42E78F0Q35002184-93113F5D-9681-4EFB-B7A2-93A9DE4DB0A8Q35150425-C3B62B99-7713-4F2E-9EB4-4E2D7FF5D94CQ36082433-11192DA8-3CD7-4C02-9E8A-C6BBD26D299EQ36334834-ED4BC882-80F7-442D-ABED-70EE8D6D9E3EQ36482820-3D19612F-8655-4A8E-8274-34EA9CE5F542Q36676374-9FC7AFF7-A8F2-43BE-9704-BDECB1A6CC9DQ36903905-62FDD8F6-F43D-4B10-8C1D-52CED062B631Q36997013-C9752DDE-ADE2-4EB0-A88E-784CBD97009EQ37100669-DD1142C0-E03F-43FC-8DF0-9ADFD0D5F22BQ37525649-AC672FD1-22D4-4569-9CEA-63593F4E7809Q37639484-5A86C72B-0546-494B-B37F-8F0F1B1ADB0FQ38164262-A7857589-6C9B-4C61-90F8-F54C2E1FE30AQ38180719-C07A616D-CC6E-40D4-B911-D6A01072ED8DQ40605870-F4C81008-35A8-4090-B11A-3065DEA5DFA3Q40942161-7D72AB54-CAAB-4CA1-B952-F5D2F97C9899Q42955909-55CBF0F8-7D71-43BB-A661-A94B89D7335DQ45855339-09F025A5-2089-4AAC-A1E3-C09D2AF8F7B5Q47291511-6A6B9FB8-6DAC-4992-8EFF-ED7F264CF64BQ47549008-7233F536-E45A-4ECF-B35B-CF8E5319C8A2Q47565629-EC08C856-CAB5-4123-BC92-4812E42DFF0EQ57827106-37F75DAF-C2CC-4CA4-8516-15925A14D429
P2860
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@en
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@nl
type
label
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@en
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@nl
prefLabel
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@en
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@nl
P2093
P2860
P1433
P1476
HIV and hepatitis C virus coin ...... table morbidity and mortality.
@en
P2093
Canadian HIV-HCV Cohort Investigators
P2860
P356
10.1111/J.1468-1293.2012.01028.X
P577
2012-05-28T00:00:00Z